David Sable

David Sable W81 M86

Portfolio Manager, Special Situations Life Sciences Fund; Adjunct Professor, Columbia University
David Sable, MD, directs healthcare and life science investing for the Special Situations Funds and is portfolio manager of the Special Situations Life Sciences Fund. After graduating from the Wharton School and the University of Pennsylvania School of Medicine, he completed his residency in obstetrics and gynecology at New York Hospital - Cornell Medical Center, and a reproductive endocrinology fellowship at Brigham and Women's Hospital. He co-founded and served as director of the Institute for Reproductive Medicine and Science at Saint Barnabas Medical Center in New Jersey, and he was founder and CEO of Assisted Reproductive Medical Technologies, a private company that was acquired in 1999. After leaving clinical medicine at age 43, David managed a proprietary healthcare portfolio at Deutsche Bank before joining the Special Situations Funds. David is an adjunct in the department of biology at Columbia University and teaches “Entrepreneurship in Biotechnology” at Columbia’s Graduate School of Arts and Sciences. He serves as a corporate director for Genenews, a Toronto-based diagnostics company, and for Hamilton Thorne, a Massachusetts-based medical-device company. He serves on the scientific advisory board for Ovascience, a biotechnology company. He has lectured on healthcare investing, policy and biotechnology business development at the Wharton School, NYU, Rockefeller University and Rutgers; has delivered keynote addresses to the American Fertility Society, the Texas Fertility Society and the Mexican Fertility Society; and appeared on the CBS Morning News, ABC World News Tonight, NY1 News and PBS’ Nova. In addition to his academic publications, he has written for the Newark Star-Ledger, Yoga Journal, Xconomy, Genetic Engineering and Biotechnology News, and the Columbia Spectator.
Wharton Magazine - Background

Type to Search

See all results